D.A. Davidson & Co. Becton Dickinson & CO Transaction History

D.A. Davidson & Co.

$12 Billion
Q3 2024

A detailed history of D.A. Davidson & Co. transactions in Becton Dickinson & CO stock. As of the latest transaction made, D.A. Davidson & Co. holds 34,174 shares of BDX stock, worth $7.69 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

34,174

Previous 33,483 2.06%

Holding current value

$7.69 Million

Previous $7.83 Million 5.29%

% of portfolio

0.07%

Previous 0.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$221.47 - $242.41 $153,035 - $167,505	691 Added 2.06%	34,174 $8.24 Million
Q2 2024 Jul 31, 2024	BUY	$225.07 - $246.17 $148,996 - $162,964	662 Added 2.02%	33,483 $7.83 Million
Q1 2024 May 13, 2024	BUY	$233.45 - $247.73 $211,972 - $224,938	908 Added 2.85%	32,821 $8.12 Million
Q4 2023 Feb 09, 2024	SELL	$232.24 - $267.23 $150,491 - $173,165	-648 Reduced 1.99%	31,913 $7.78 Million
Q3 2023 Nov 08, 2023	BUY	$254.9 - $283.59 $128,469 - $142,929	504 Added 1.57%	32,561 $8.42 Million
Q2 2023 Aug 10, 2023	BUY	$238.39 - $265.32 $148,516 - $165,294	623 Added 1.98%	32,057 $8.46 Million
Q1 2023 Apr 25, 2023	BUY	$229.71 - $259.35 $89,586 - $101,146	390 Added 1.26%	31,434 $7.78 Million
Q4 2022 Feb 03, 2023	SELL	$218.29 - $256.91 $16,808 - $19,782	-77 Reduced 0.25%	31,044 $7.9 Million
Q3 2022 Nov 07, 2022	SELL	$51.03 - $264.23 $28,117 - $145,590	-551 Reduced 1.74%	31,121 $6.94 Million
Q2 2022 Jul 28, 2022	BUY	$234.74 - $275.42 $33,567 - $39,385	143 Added 0.45%	31,672 $7.81 Million
Q1 2022 May 12, 2022	BUY	$243.64 - $270.48 $138,874 - $154,173	570 Added 1.84%	31,529 $8.39 Million
Q4 2021 Jan 31, 2022	BUY	$230.08 - $250.94 $91,571 - $99,874	398 Added 1.3%	30,959 $7.79 Million
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $797,531 - $878,922	-3,427 Reduced 10.08%	30,561 $7.51 Million
Q2 2021 Aug 10, 2021	BUY	$232.65 - $254.58 $103,994 - $113,797	447 Added 1.33%	33,988 $8.27 Million
Q1 2021 May 07, 2021	BUY	$232.09 - $256.88 $521,970 - $577,723	2,249 Added 7.19%	33,541 $8.16 Million
Q4 2020 Feb 10, 2021	BUY	$221.92 - $245.94 $219,700 - $243,480	990 Added 3.27%	31,292 $7.83 Million
Q3 2020 Nov 02, 2020	SELL	$215.77 - $276.76 $61,710 - $79,153	-286 Reduced 0.94%	30,302 $7.05 Million
Q2 2020 Aug 10, 2020	BUY	$219.9 - $263.41 $204,067 - $244,444	928 Added 3.13%	30,588 $7.32 Million
Q1 2020 May 05, 2020	BUY	$195.69 - $279.01 $259,093 - $369,409	1,324 Added 4.67%	29,660 $6.79 Million
Q4 2019 Feb 14, 2020	BUY	$236.45 - $266.82 $783,358 - $883,974	3,313 Added 13.24%	28,336 $7.7 Million
Q3 2019 Nov 05, 2019	SELL	$230.58 - $256.08 $73,093 - $81,177	-317 Reduced 1.25%	25,023 $6.33 Million
Q2 2019 Aug 13, 2019	SELL	$217.4 - $246.08 $2.91 Million - $3.29 Million	-13,376 Reduced 34.55%	25,340 $6.39 Million
Q1 2019 May 13, 2019	BUY	$206.05 - $248.17 $617,325 - $743,517	2,996 Added 8.39%	38,716 $9.09 Million
Q4 2018 Jan 29, 2019	BUY	$204.73 - $257.93 $1.84 Million - $2.32 Million	8,985 Added 33.61%	35,720 $8.05 Million
Q3 2018 Nov 13, 2018	SELL	$233.07 - $256.0 $60,132 - $66,048	-258 Reduced 0.96%	26,735 $6.98 Million
Q2 2018 Aug 02, 2018	SELL	$208.1 - $233.85 $25,180 - $28,295	-121 Reduced 0.45%	26,993 $6.47 Million
Q1 2018 May 04, 2018	BUY	$205.46 - $240.27 $98,209 - $114,849	478 Added 1.79%	27,114 $5.88 Million
Q4 2017 Feb 08, 2018	SELL	$189.0 - $222.64 $26,082 - $30,724	-138 Reduced 0.52%	26,636 $5.7 Million
Q3 2017 Nov 08, 2017	SELL	$186.89 - $198.9 $891,465 - $948,753	-4,770 Reduced 15.12%	26,774 $5.25 Million
Q2 2017 Aug 11, 2017	BUY	N/A	31,544	31,544 $0

Others Institutions Holding BDX

# of Institutions

1,735

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account